Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions
Endocannabinoid-metabolizing enzymes are downregulated in response to lipopolysaccharide (LPS)-induced inflammation in mice, which may serve as a negative feedback mechanism to increase endocannabinoid levels and reduce inflammation. Increased plasma levels of the pro-inflammatory cytokine interleuk...
Main Authors: | Brittany N. Szafran, Jung Hwa Lee, Abdolsamad Borazjani, Peter Morrison, Grace Zimmerman, Kelly L. Andrzejewski, Matthew K. Ross, Barbara L.F. Kaplan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/23/12/3167 |
Similar Items
-
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
by: Adriana Della Pietra, et al.
Published: (2022-04-01) -
The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation
by: Ahmet Ulugöl
Published: (2014-06-01) -
A Guide to Targeting the Endocannabinoid System in Drug Design
by: Adam Stasiulewicz, et al.
Published: (2020-04-01) -
The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
by: Robert Ramer, et al.
Published: (2021-11-01) -
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
by: Justin Matheson, et al.
Published: (2021-12-01)